Po Wang, MD
Psychiatry · Palo Alto, CANPI 1982748018
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,230 of the $4,230 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Genentech, Inc.. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2 payments — averaging $2115.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$4K
Across 9 payments — averaging $22,667 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$204K
What the payments were for
- Consulting fees$4,230100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 2 | $4,230 |
How this compares
$4,230 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 20 | $34,561 |
| BelsomraSuvorexant | 24 | $10,046 |
| FetzimaLevomilnacipran Hcl | 11 | $6,260 |
| Lurasidone Hcl | 50 | $2,407 |
| Quetiapine Fumarate | 64 | $1,179 |
| Duloxetine Hcl | 45 | $1,145 |
| Modafinil | 13 | $1,142 |
| Aripiprazole | 40 | $913 |
| Lamotrigine | 64 | $848 |
| Gabapentin | 40 | $828 |
| Bupropion XlBupropion Hcl | 29 | $726 |
| Divalproex Sodium | 13 | $570 |
| Escitalopram Oxalate | 18 | $483 |
| Mirtazapine | 13 | $443 |
| Trazodone Hcl | 24 | $363 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Palo Alto
- Julie BonnerPalo Alto$252K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.